Viewing StudyNCT00329628



Ignite Creation Date: 2024-05-05 @ 4:50 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00329628
Status: COMPLETED
Last Update Posted: 2014-10-28
First Post: 2006-05-24

Brief Title: Rivaroxaban 10mg Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin
Sponsor: Bayer
Organization: Bayer

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-02
Start Date Type: None
Primary Completion Date: 2007-03
Primary Completion Date Type: ACTUAL
Completion Date: 2007-03
Completion Date Type: ACTUAL
First Submit Date: 2006-05-24
First Submit QC Date: May 24 2006
Study First Post Date: 2006-05-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-10-27
Last Update Post Date: 2014-10-28
Last Update Post Date Type: ESTIMATED